Therapeutic Trem2 activation ameliorates amyloid-beta deposition and improves cognition in the 5XFAD model of amyloid depositionBrittani R. Price(University of Kentucky), Donna M. Wilcock(Institute for Neurodegenerative Disorders)Journal of NeuroinflammationAugust 14, 202010.1186/s12974-020-01915-0Cited by 144SaveCiteExport RISWatch citationsRelated PapersProgression of Amyloid Pathology to Alzheimer's Disease Pathology in an Amyloid Precursor Protein Transgenic Mouse Model by Removal of Nitric Oxide Synthase 2|Journal of Neuroscience|2008|194Time-course of glial changes in the hyperhomocysteinemia model of vascular cognitive impairment and dementia (VCID)|Neuroscience|2016|72